Moyamoya disease in Europe, past and present status
Moyamoya disease in Europe, past and present status
复制标题
DOI：
10.1016/s0303-8467(97)00042-5
复制
发表时间：
1997-10-01
影响因子：
1.9
通讯作者：
Imhof, HG
中科院分区：
文献类型：
--
作者：
Yonekawa, Y;Ogata, N;Imhof, HG
1996年初，向160个欧洲主要的神经科、神经儿科和神经外科中心分发了一份问卷，以评估欧洲烟雾病的现状。有效率为43%。总共获得了168名患者的资料，其中110人在1992年之前就诊，58人在1993年以后就诊。82%的患者是高加索人。在所有其他方面，临床结果与在日本观察到的相似。目前的研究表明，每个中心每年的发病率为0.3人，大约是日本发病率的十分之一。除了这些结果，还简要讨论了欧洲对这种疾病的认识和治疗的历史。(C)1997年爱思唯尔科学公司。
A questionnaire was distributed in early 1996 to 160 leading European neurological, neuro-pediatric and neurosurgical centers to assess the present status of Moyamoya disease in Europe. The response rate was 43%. Information was obtained on a total of 168 patients, of whom 110 had presented before 1992, and 58 from 1993 onward. 82% of the patients were Caucasian. In all other respects, the clinical findings were similar to those observed in Japan. The present study yields an incidence of 0.3 patients per center per year, which is approximately one-tenth of the incidence in Japan. Alongside these results, the history of the recognition and treatment of this disease in Europe is briefly discussed. (C) 1997 Elsevier Science B.V.